U.S. markets close in 6 hours 20 minutes

Immunome, Inc. (IMNM)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
22.67+0.17 (+0.76%)
As of 9:30AM EDT. Market open.
Sign in to post a message.
  • j
    jon
    This news is quite revealing to me. Now why would a distinguished professional leave a major firm for IMNM, unless they perceived major upside in the 120k options that is part of the pay package. Had a secure well paying job, hmmm - to me it lends much credibility to what IMNM is doing. Corleen Roche is a corporate finance and business strategist with extensive executive experience in the biopharmaceutical industry. Prior to her most recent role as the U.S. CFO for Biogen, Ms. Roche was a CFO at various biopharmaceutical companies including Sandoz, IoGenetics Inc, and Wyeth Pharmaceuticals.
    Bullish
  • W
    Wing
    Look at ODT, buy on hope is risky!!
  • n
    nicholas
    what is the connection between $IMNM and $ENZC? Enzolytics COO Tweeted this morning and hashtagged #Immunome.
  • j
    jon
    Seems like incredibly positive news to me
  • T
    T Crown
    $IPA is way ahead of IMNM, check out the PR from last Friday. 100% clearance of covid in in vivo preclinical.
  • C
    CanooMan
    Anybody know if this offers anything better than Gritstone’s current NIAID trial for a similar thing?
  • B
    Benpattan
    I figure they have something over $50 mm million so an offering would be likely if the stock holds up but isn’t urgent.
  • R
    Ravi
    Up trend stated. Coronavirus antibody breakthrough is crucial now.
    Bullish
  • w
    wanderley
    This will fly tomorrow
  • M
    Mark
    Good news coming for IMNM
    Bullish
  • J
    Jacqueline
    Bought in the 60s - it's mooning!!!
  • N
    Nibor
    Premarket could be good clean fun tomorrow morning.
    Bullish
  • F
    Frank
    next week to 100s
    Bullish
  • p
    pundit
    I’d wait for the secondary,, they have no money and need to dilute.
    Great science, great space , just need to wait for the next offer before jumping in
    Neutral
  • M
    ME
    Soon over 60.00
  • B
    Baja4wd
    Its rumored by industry sources that Immunome has drawn the interest of major investors after the recent announcement that it has isolated potent antibodies capable of neutralizing several SARS-CoV-2 variants, including the South African Variant in pseudo virus testing. This discovery has tripled the stock prices of Immunome and opened the doors for nearly 2M shares traded today compared to a normal trading day volume of +/- 90,000 shares. It’s a windfall for the Biotech Industry in the fight to combat the Covid-19 virus and Immunome is at the forefront.
    Bullish
  • F
    Frank
    way undervalued, I think many didn't saw the last PR, and maybe many don't know any about what's happening in EUROPE with the UK COVID-19 virus...
    Bullish
  • S
    Stefano
    This could be a 500 dollar stock literally. Its the most important thing happening in the market.
    Bullish
  • B
    Benpattan
    Secondary coming first, then we take off!
  • M
    ME
    Webull you can buy premarket 4am Monday